Quarterly report [Sections 13 or 15(d)]

Unaudited Interim Condensed Consolidated Statements of Cash Flows

v3.26.1
Unaudited Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows From Operating Activities:    
Net income / (loss) $ 2,154 $ (3,493)
Adjustments to reconcile net income (loss) to net cash and restricted cash used in operating activities:    
Change in gain on sale of business 344 0
Depreciation and amortization 3,060 1,697
Stock-based compensation 5,035 4,217
Change in fair value of warrant liabilities (1,459) (2,752)
Change in fair value of other assets and liabilities (3,444) 0
Accretion of interest income on held-to-maturity securities (265) (723)
Deferred tax expense (77) (17)
Other 27 93
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 383 2,254
Accounts receivable 149 (520)
Other non-current assets 78 13
Operating right-of-use assets/lease liabilities 73 (30)
Accounts payable and accrued expenses (2,158) (2,278)
Deferred revenue (3) 1,293
Other (12) 0
Net cash provided by/ (used in) operating activities (includes discontinued operations; see Note 4) 3,885 (246)
Cash Flows From Investing Activities:    
Cash transfer related to sale of business (290) 0
Capitalized software development costs (302) (532)
Purchase of property and equipment, net of proceeds from disposal (5,179) (2,614)
Purchase of held-to-maturity investments 0 (84,197)
Proceeds from maturities of held-to-maturity investments 30,500 107,750
Net cash provided by investing activities (includes discontinued operations; see Note 4) 24,729 20,407
Cash Flows From Financing Activities:    
Proceeds from the exercise of common stock options 52 60
Taxes paid related to net share settlement of equity awards (582) (4,306)
Payments for debt issuance costs (329) 0
Net cash used in financing activities (includes discontinued operations; see Note 4) (859) (4,246)
Effect of foreign exchange rate changes on cash balances 0 126
Net increase in cash and cash equivalents and restricted cash 27,755 16,041
Cash and cash equivalents and restricted cash - beginning 31,232 19,647
Cash and cash equivalents and restricted cash - ending 58,987 35,688
Reconciliation to consolidated balance sheet (includes discontinued operations; see Note 4)    
Cash and cash equivalents 58,723 34,830
Restricted cash 264 858
Total cash and cash equivalents and restricted cash 58,987 35,688
Non-cash investing and financing activities:    
New leases under ASC 842 entered into during the period 1,317 608
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses $ 161 $ 339